Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry
暂无分享,去创建一个
E. Romagnoli | F. Burzotta | A. Colombo | G. Sangiorgi | C. Briguori | G. Sardella | D. Capodanno | G. Biondi‐Zoccai | S. Servi | P. Presbitero | I. Sheiban | C. Tamburino | P. Rubino | L. Piatti | L. Bolognese | C. Greco | L. Niccoli | L. Paloscia | G. Franco | Domenico Di Girolamo
[1] Pierfrancesco Agostoni,et al. Are propensity scores really superior to standard multivariable analysis? , 2011, Contemporary clinical trials.
[2] G. Biondi-Zoccai,et al. Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients , 2011, Clinical Research in Cardiology.
[3] S. de Servi,et al. Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS). , 2010, American heart journal.
[4] Seung‐Jung Park,et al. Long-term outcomes of intravascular ultrasound-guided stenting in coronary bifurcation lesions. , 2010, The American journal of cardiology.
[5] Y. Jang,et al. Serial changes of minimal stent malapposition not detected by intravascular ultrasound: follow-up optical coherence tomography study , 2010, Clinical Research in Cardiology.
[6] J. Veselka,et al. CORONARY ARTERY DISEASE Original Studies Long-Term Health Outcome and Mortality Evaluation After Invasive Coronary Treatment Using Drug Eluting Stents with or without the IVUS Guidance. Randomized Control Trial. HOME DES IVUS , 2010 .
[7] C. Nienaber,et al. Coronary stenting with the sirolimus-eluting stent in patients with restenosis after intracoronary brachytherapy: results from the prospective multicentre German Cypher Stent Registry , 2010, Clinical Research in Cardiology.
[8] G. Biondi-Zoccai,et al. Impact of routine angiographic follow-up after percutaneous coronary drug-eluting stenting for unprotected left main disease: the Turin Registry , 2010, Clinical Research in Cardiology.
[9] Pierfrancesco Agostoni,et al. Quantitative coronary angiography in the current era: principles and applications. , 2009, Journal of interventional cardiology.
[10] G. Biondi-Zoccai,et al. A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions , 2009, Acta cardiologica.
[11] R. Blindt,et al. The risk of definitive stent thrombosis is increased after “off-label” stent implantation irrespective of drug-eluting stent or bare-metal stent use , 2009, Clinical Research in Cardiology.
[12] Young-Hak Kim,et al. Impact of Intravascular Ultrasound Guidance on Long-Term Mortality in Stenting for Unprotected Left Main Coronary Artery Stenosis , 2009, Circulation. Cardiovascular interventions.
[13] P. Teirstein,et al. A Randomized Controlled Trial of Angiography Versus Intravascular Ultrasound-Directed Bare-Metal Coronary Stent Placement (The AVID Trial) , 2009, Circulation. Cardiovascular interventions.
[14] D. Capodanno,et al. A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score , 2009, Clinical Research in Cardiology.
[15] K. Kent,et al. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents , 2008 .
[16] W. Howard,et al. Optimal Medical Therapy with or without PCI for Stable Coronary Disease , 2008 .
[17] A. Colombo,et al. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications. , 2007, The American journal of cardiology.
[18] Simon Wandel,et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis , 2007, The Lancet.
[19] D. Berman,et al. Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.
[20] G. Biondi-Zoccai,et al. Applying intravascular ultrasound to optimize the placement of coronary drug-eluting stents. , 2005, Minerva Cardioangiologica : a Journal on Cardiovascular Pathophysiology, Clinical Medicine and Therapy.
[21] P. Serruys,et al. Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. , 2005, The American journal of cardiology.
[22] U. Siebert,et al. Impact of intravascular ultrasound‐guided stenting on long‐term clinical outcome: A meta‐analysis of available studies comparing intravascular ultrasound‐guided and angiographically guided stenting , 2003 .
[23] C. Di Mario,et al. Randomized Comparison of Coronary Stent Implantation Under Ultrasound or Angiographic Guidance to Reduce Stent Restenosis (OPTICUS Study) , 2001, Circulation.
[24] K. Detre,et al. Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry). , 2001, The American journal of cardiology.
[25] J. Tobis,et al. Comparison of immediate and intermediate-term results of intravascular ultrasound versus angiography-guided Palmaz-Schatz stent implantation in matched lesions. , 1997, Circulation.